আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
cofact stungulyfsstofn og leysir, lausn 500 a.e.
prothya biosolutions netherlands b.v. - factor ii human; factor vii human; factor ix human; factor x human - stungulyfsstofn og leysir, lausn - 500 a.e.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
octaplex innrennslisstofn og leysir, lausn 500 a.e.
octapharma ab - factor ii human; factor vii human; factor ix human; factor x human; protein c; protein s - innrennslisstofn og leysir, lausn - 500 a.e.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
salazopyrin en-tabs magasýruþolin tafla 500 mg
pfizer aps - sulfasalazinum inn - magasýruþolin tafla - 500 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
colrefuz tafla 500 míkróg
teva b.v.* - colchicinum - tafla - 500 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
desferal stungulyfs-/innrennslisstofn, lausn 500 mg
novartis healthcare a/s - deferoxaminum mesýlat - stungulyfs-/innrennslisstofn, lausn - 500 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
flixotide (flixotide diskos) innöndunarduft 500 míkróg/skammt
glaxosmithkline pharma a/s* - fluticasonum própíónat - innöndunarduft - 500 míkróg/skammt
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
meropenem sun stungulyfs-/innrennslisstofn, lausn 500 mg
sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
pinex endaþarmsstíll 500 mg
teva b.v.* - paracetamolum inn - endaþarmsstíll - 500 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
salazopyrin tafla 500 mg
pfizer aps - sulfasalazinum inn - tafla - 500 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
paracetamol medical valley filmuhúðuð tafla 500 mg
medical valley invest ab - paracetamolum inn - filmuhúðuð tafla - 500 mg